loader
Please Wait
Applying Filters...
menu
    • menu

    List of Drug Master Files (KDMF) for Leuprolide Active Pharmaceutical Ingredient (API) submitted to the Review Authority in Korea.

    Client Email Product
    2024 US Elections: Harris, Trump differ on abortion rights, ACA, public health spends; agree on need to cut drug prices

    Data Compilation
    #PharmaFlow

    Pipeline Prospector Aug 2024: Otsuka buys Jnana, Lilly’s market cap gains by over US$ 108 bn post new guidance

    Stock Recap
    #PipelineProspector

    Menu

    Leuprolide

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    PRICE INFORMATION

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 128,417Xls download

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    Data in the table can be downloaded after upgrading. In the meantime, you can access the data through the menu.

    Last Updated on PharmaCompass Virtual Booth Country Registrant Name Registration No. Compound Registration Date Manufacturer Manufacturer's Country Manufacturer's Address
    28/09/2024 Bachem AG
    Switzerland
    		 Hiple Co., Ltd. 20221207-210-J-1398 Leuprorelin acetate 2022-12-07 Bachem AG Switzerland Hauptstrasse 144, 4416 Bubendorf, Switzerland
    28/09/2024 Anygen
    South Korea
    		 Anygen Inc. 20180829-210-J-257 Leuprorelin acetate 2018-08-29 Anygen Inc. South Korea 123 Nanosandan-ro, Nammyeon, Jangseong-gun, Jeollanam-do, Test Production Building 2 (3-story building) in the Jeollanam-do Nanobio Center